<?xml version="1.0" encoding="UTF-8"?>
<fig id="vaccines-07-00070-f005" orientation="portrait" position="float">
 <label>Figure 5</label>
 <caption>
  <p>Models of HCMV entry into human cells using the trimer complex (TC) or PC complexes. The TC interacts with PDGFRÎ± via gO, then gH/gL/gO activates the fusogenic activity of gB at the plasma membrane of human fibroblasts. Conversely, the PC first binds Nrp2, then the gH/gL component of the PC (or gH/gL/gO) induces endocytosis of virus particles [
   <xref rid="B71-vaccines-07-00070" ref-type="bibr">71</xref>], which are released into cytoplasm from endosomal membranes, following low-pH-induced activation of the gB fusion machinery (from [
   <xref rid="B72-vaccines-07-00070" ref-type="bibr">72</xref>]).
  </p>
 </caption>
 <graphic xlink:href="vaccines-07-00070-g005" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
